Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon vs butorphanol for postoperative analgesia after cholecystectomy
ChiCTR2600117757Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Jan 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of hsk21542 in postoperative pain (2 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: Numeric Rating Scale (NRS) pain scores within 48 hours postoperatively (area under curve) and Composite incidence of opioid-related adverse events (ORADEs). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117757.